These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11536039)

  • 1. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice.
    Reese JS; Allay E; Gerson SL
    Oncogene; 2001 Aug; 20(38):5258-63. PubMed ID: 11536039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
    Allay E; Veigl M; Gerson SL
    Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
    Allay E; Reese JS; McGuire EA; Koç ON; Sedransk N; Gerson SL
    Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid repair of O6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas.
    Liu L; Allay E; Dumenco LL; Gerson SL
    Cancer Res; 1994 Sep; 54(17):4648-52. PubMed ID: 8062258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis.
    Qin X; Zhou H; Liu L; Gerson SL
    Carcinogenesis; 1999 Sep; 20(9):1667-73. PubMed ID: 10469609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.
    Qin X; Liu L; Gerson SL
    Oncogene; 1999 Jul; 18(30):4394-400. PubMed ID: 10439048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
    Mangues R; Kahn JM; Seidman I; Pellicer A
    Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: evidence of elimination of p53 by homologous recombination.
    Boley SE; McManus TP; Maher VM; McCormick JJ
    Cancer Res; 2000 Aug; 60(15):4105-11. PubMed ID: 10945617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
    Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
    Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea.
    Brathwaite O; Bayona W; Newcomb EW
    Cancer Res; 1992 Jul; 52(13):3791-5. PubMed ID: 1617648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.
    Zaidi NH; Allay E; Ayi TC; Li BF; Dumenco LL; Sy MS; Gerson SL
    Carcinogenesis; 1995 May; 16(5):1047-53. PubMed ID: 7767963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnitrosourea-induced tumorigenesis in MGMT gene knockout mice.
    Sakumi K; Shiraishi A; Shimizu S; Tsuzuki T; Ishikawa T; Sekiguchi M
    Cancer Res; 1997 Jun; 57(12):2415-8. PubMed ID: 9192819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice.
    Kawate H; Itoh R; Sakumi K; Nakabeppu Y; Tsuzuki T; Ide F; Ishikawa T; Noda T; Nawata H; Sekiguchi M
    Carcinogenesis; 2000 Feb; 21(2):301-5. PubMed ID: 10657972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyltransferase transgenic mice: probes of chemical carcinogenesis.
    Gerson SL; Zaidi NH; Dumenco LL; Allay E; Fan CY; Liu L; O'Connor PJ
    Mutat Res; 1994 Jun; 307(2):541-55. PubMed ID: 7514728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of O6-alkylguanine during DNA synthesis in murine bone marrow hematopoietic precursors.
    Gerson SL; Trey JE; Miller K; Benjamin E
    Cancer Res; 1987 Jan; 47(1):89-95. PubMed ID: 3539320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carcinogenicity studies.
    Morton D; Bailey KL; Stout CL; Weaver RJ; White KA; Lorenzen MJ; Ball DJ
    Toxicol Pathol; 2008 Dec; 36(7):926-31. PubMed ID: 18827072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice.
    Benavides F; Gomez G; Venables-Griffith A; Lambertz I; Flores M; Angel JM; Fuchs-Young R; Richie ER; Conti CJ
    Mol Carcinog; 2006 Jul; 45(7):543-8. PubMed ID: 16479612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic and cellular events during radiation-induced thymic lymphomagenesis in the p53 heterozygous (+/-) B10 mouse.
    Tanaka K; Watanabe K; Mori M; Kamisaku H; Tsuji H; Hirabayashi Y; Inoue T; Yoshida K; Aizawa S
    Int J Radiat Biol; 2002 Mar; 78(3):165-72. PubMed ID: 11869471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.